Independent fund research. Built on SEC filings.

How we research funds

Fund comparison

XLV vs. PHLAX: which is better?

Bottom line

XLV vs PHLAX: the short answer

XLV (State Street(R) Health Care Select Sector SPDR(R) ETF) and PHLAX (PGIM Jennison Health Sciences Fund) share a meaningful slice of their top holdings — about 50% by weight.

XLV is cheaper at 0.08% vs 1.15% — a difference of $107 a year per $10,000 invested.

Over five years, XLV returned +8.1% a year vs +5.5% for PHLAX (reporting dates differ).

PHLAX has a front-end sales load of up to 5.5%; the other does not.

Updated Nov 19, 2026

XLV vs PHLAX side by side

XLVPHLAX
TypeETFMutual fund
Fund familySPDR (State Street)PGIM (Prudential)
CategoryHealth Care SectorHealth Care Sector
Expense ratio0.08%1.15%
Annual cost per $10k$8$115
10-yr cost on $10k (prospectus)$103$1,871
Max front loadNone5.5%
12b-1 fee0.02%0.3%
1-yr return+14.5%+12.7%
5-yr return (annualized)+8.1%+5.5%
10-yr return (annualized)+9.8%+8.9%
Best quarter+14.5%—
Worst quarter−12.7%—
Net assets (fund)$40.6B$1.4B
Number of holdings6555
Portfolio turnover2%81%
Returns as ofDec 31, 2025Dec 31, 2024

Source: SEC Form N-PORT and fund prospectuses

Holdings overlap

9 of XLV's top 25 holdings also appear in PHLAX's top 25.

Shared top holdings
HoldingXLVPHLAX
Eli Lilly & Co16.51%17.35%
UnitedHealth Group Inc6.57%5.87%
Merck & Co Inc5.52%6.06%
Thermo Fisher Scientific Inc3.24%4.56%
Intuitive Surgical Inc2.45%3.07%
CVS Health Corp2.30%2.52%
Vertex Pharmaceuticals Inc2.19%3.37%
Danaher Corp2.09%3.28%
Stryker Corp1.89%2.16%

Source: SEC Form N-PORT

XLV top 10

  1. Eli Lilly & Co — 16.51%
  2. Johnson & Johnson — 10.64%
  3. AbbVie Inc — 7.74%
  4. UnitedHealth Group Inc — 6.57%
  5. Merck & Co Inc — 5.52%
  6. Amgen Inc — 3.40%
  7. Thermo Fisher Scientific Inc — 3.24%
  8. Abbott Laboratories — 2.75%
  9. Gilead Sciences Inc — 2.73%
  10. Intuitive Surgical Inc — 2.45%

PHLAX top 10

  1. Eli Lilly & Company — 17.35%
  2. Merck & Company Inc — 6.06%
  3. Unitedhealth Group Inc — 5.87%
  4. Thermo Fisher Scientific Inc — 4.56%
  5. Argenx Se — 3.55%
  6. Vertex Pharmaceuticals Inc — 3.37%
  7. Danaher Corp — 3.28%
  8. Intuitive Surgical Inc — 3.07%
  9. Lonza Group Ag — 3.02%
  10. Cvs Health Corp — 2.52%

FAQ

What is the difference between XLV and PHLAX?
XLV (State Street(R) Health Care Select Sector SPDR(R) ETF) and PHLAX (PGIM Jennison Health Sciences Fund) share a meaningful slice of their top holdings — about 50% by weight. XLV is cheaper at 0.08% vs 1.15% — a difference of $107 a year per $10,000 invested.
Which is cheaper, XLV or PHLAX?
XLV has the lower expense ratio (0.08%).
Should I own both XLV and PHLAX?
Because their portfolios differ, owning both can add diversification — check how they fit your overall allocation.

Educational comparison based on public filings; not investment advice. Past performance does not guarantee future results.